創新藥物
創新藥板塊聚焦原創藥物從靶點發現到臨床轉化與商業化全鏈條。核心賽道涵蓋小分子、單抗/雙抗與ADC、細胞與基因治療、核酸藥物及CRO/CMO。該板塊總市值為 1786.68 billion HKD，24h 漲跌幅 -1.08%，40 檔中，7 檔上漲 (17.50%)，32 檔下跌 (80.00%)。領漲個股為 樂普生物－Ｂ (02157)，24h 漲幅為 +5.40%。漲跌家數參差，板塊回落，但龍頭股表現相對優異。保持選擇性：圍繞臨床或政策催化事件操作；偏好現金充裕、處於後期臨床階段的研發管線，並在走弱時逢低加碼，因利率與給付/報銷訊號將影響估值。
名稱 | 最新價 | 漲跌幅 | 最新價 / 漲跌幅 | 走勢圖 | 價格區間 | 操作 |
|---|---|---|---|---|---|---|
 亞盛醫藥－Ｂ06855 | HK$35.24$145.27 | -2.00%-$2.96 | HK$35.24 -2.00% | $145.27$149.06 | ||
 諾誠健華09969 | HK$13.89$57.26 | -0.14%-$0.08 | HK$13.89 -0.14% | $56.64$57.96 | ||
 四環醫藥00460 | HK$0.93$3.83 | -1.06%-$0.04 | HK$0.93 -1.06% | $3.62$3.91 | ||
 綠葉製藥02186 | HK$2.06$8.49 | +0.48%+$0.04 | HK$2.06 +0.48% | $8.45$8.57 | ||
 聯邦制藥03933 | HK$8.95$36.89 | -1.54%-$0.57 | HK$8.95 -1.54% | $36.89$37.51 | ||
 先聲藥業02096 | HK$12.66$52.19 | +0.31%+$0.16 | HK$12.66 +0.31% | $51.53$52.47 | ||
 同源康醫藥－Ｂ02410 | HK$7.28$30.01 | +0.13%+$0.04 | HK$7.28 +0.13% | $28.93$30.09 | ||
 雲頂新耀－Ｂ01952 | HK$24.62$101.49 | -2.30%-$2.39 | HK$24.62 -2.30% | $101.49$104.62 | ||
 復星醫藥02196 | HK$16.04$66.12 | -0.98%-$0.65 | HK$16.04 -0.98% | $66.12$67.32 | ||
 和黃醫藥00013 | HK$17.41$71.77 | -1.41%-$1.03 | HK$17.41 -1.41% | $71.77$73.13 | ||
 華潤醫藥03320 | HK$4.79$19.74 | -0.20%-$0.04 | HK$4.79 -0.20% | $19.70$19.78 | ||
 海西新藥02637 | HK$172.6$711.5 | -3.14%-$23.0 | HK$172.6 -3.14% | $711.5$746.1 | ||
 博安生物06955 | HK$4.71$19.41 | -3.08%-$0.61 | HK$4.71 -3.08% | $19.41$20.15 | ||
 錦欣生殖醫療集團有限公司01951 | HK$2.21$9.11 | 0.00%$0.00 | HK$2.21 0.00% | $9.11$9.23 | ||
 歌禮製藥－Ｂ01672 | HK$8.92$36.77 | -2.72%-$1.03 | HK$8.92 -2.72% | $36.56$37.80 | ||
 遠大醫藥00512 | HK$5.09$20.98 | -1.16%-$0.24 | HK$5.09 -1.16% | $20.98$21.47 | ||
 麗珠醫藥01513 | HK$25.58$105.45 | -1.31%-$1.40 | HK$25.58 -1.31% | $105.45$107.43 | ||
 石四藥集團02005 | HK$2.40$9.89 | +0.41%+$0.04 | HK$2.40 +0.41% | $9.85$9.93 | ||
 歐康維視生物－Ｂ01477 | HK$5.37$22.13 | 0.00%$0.00 | HK$5.37 0.00% | $22.13$23.04 | ||
 HUA HAO ZHONG TIAN PHARMACEUTICAL-B02563 | HK$3.55$14.63 | -0.83%-$0.12 | HK$3.55 -0.83% | $14.42$15.25 |